Stemline Therapeutics, Inc.

This completed Phase 3 trial tested whether a new oral drug called elacestrant works better than standard hormone therapies for people with advanced breast cancer that has grown despite previous treatments. The study involved 478 men and postmenopausal women whose cancer had spec…